Comparison of the midterm results of simple arthroscopic microfracture with or without platelet-rich plasma in the treatment of osteochondral lesions of the talus

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000032661

Enrollment

Unknown

Registered

2020-05-05

Start date

2015-01-01

Completion date

Unknown

Last updated

2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteochondral lesions of the talus of ankle joint

Interventions

experimental group:arthroscopic microfracture with platelet-rich plasma injection

control group:simple arthroscopic microfracture

Eligibility

Sex/Gender

All

Age

19 Years to 59 Years

Inclusion criteria

Inclusion criteria: Aged > 18-60 years, initial operation, talus cartilage damage area less than 1.5 cm 2.

Exclusion criteria

Exclusion criteria: Pregnant women, ankle joint infection or poor skin condition, cartilage damage diameter > 15 mm.

Design outcomes

Primary

Measure	Time frame
American Orthopaedic Foot and Ankle Society (AOFAS);visual analogue scale (VAS);	—

Countries

China

Contacts

Public ContactJia Yanbo

The Second Affiliated Hospital of Inner Mongolia Medical University

kmygyt@163.com+86 13847169058

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026